Chocolate bridge mix in 10 oz, 3 oz, and 3.5 oz bags
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1042-2013.
The product is being recalled because it was manufactured using peanuts that were recalled by Peanut Corporation of America because of their potential to be contaminated with Salmonella.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1042-2013.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Gorant Candies Inc A Division Of Carlton Cards Retail Inc or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1042-2013.
Gorant Candies Inc A Division of Carlton Cards Retail Inc
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Gorant Candies Inc A Division Of Carlton Cards Retail Inc Recall FAQ
Gorant Candies Inc A Division Of Carlton Cards Retail Inc is the subject of a snacks & candy safety report: Chocolate bridge mix in 10 oz, 3 oz, and 3.5 oz bags. The notice was published on February 3, 2009 by the U.S. Food and Drug Administration (FDA). Approximately 14,762 units are potentially affected.